For the quarter ending 2026-03-31, SANA has $373,593K in assets. $254,353K in debts. $83,800K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 83,800 | 71,870 | 103,357 | 71,271 |
| Marketable securities | 17,336 | 66,512 | 49,697 | 1,403 |
| Restricted cash | 4,195 | 4,195 | 4,195 | 4,195 |
| Prepaid expenses and other current assets | 6,359 | 6,099 | 4,510 | 5,633 |
| Total current assets | 111,690 | 148,676 | 161,759 | 82,502 |
| Property and equipment, at cost | 82,819 | 81,661 | 83,774 | - |
| Less accumulated depreciation | 57,146 | 54,755 | 53,843 | - |
| Property and equipment, net | 25,673 | 26,906 | 29,931 | 33,081 |
| Operating lease right-of-use assets | 35,845 | 38,313 | 40,704 | 43,021 |
| Intangible asset | 59,195 | 59,195 | 59,195 | 59,195 |
| Goodwill | 140,627 | 140,627 | 140,627 | 140,627 |
| Other non-current assets | 563 | 3,173 | 3,216 | 3,219 |
| Total assets | 373,593 | 416,890 | 435,432 | 361,645 |
| Accounts payable | 2,123 | 1,669 | 1,858 | 2,270 |
| Accrued compensation | 7,584 | 13,240 | 11,296 | 9,411 |
| Accrued expenses and other current liabilities | 8,124 | 8,679 | 7,991 | 7,931 |
| Operating lease liabilities | 14,878 | 14,938 | 14,368 | 13,832 |
| Contingent consideration | 53,556 | 40,200 | - | - |
| Total current liabilities | 86,265 | 78,726 | 35,513 | 33,444 |
| Operating lease liabilities, net of current portion | 60,450 | 63,924 | 67,868 | 71,660 |
| Contingent consideration, net of current portion | 80,907 | 83,518 | 115,141 | 117,132 |
| Success payment liabilities | 16,926 | 19,238 | 13,726 | 8,611 |
| Other non-current liabilities | 9,805 | 10,600 | 7,876 | 8,242 |
| Total liabilities | 254,353 | 256,006 | 240,124 | 239,089 |
| Common stock, 0.0001 par value 750,000 shares authorized 269,817 and 266,732 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 27 | 27 | 26 | 23 |
| Additional paid-in capital | 2,015,441 | 2,009,845 | 1,985,452 | 1,870,572 |
| Accumulated other comprehensive income (loss) | -2 | 28 | 21 | 0 |
| Accumulated deficit | -1,896,226 | -1,849,016 | -1,790,191 | -1,748,039 |
| Total stockholders' equity | 119,240 | 160,884 | 195,308 | 122,556 |
| Total liabilities and stockholders' equity | 373,593 | 416,890 | 435,432 | 361,645 |
Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. (SANA)